Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IGC save search
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Published: 2021-06-09 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 0.64%
H: 1.9%
C: -5.7%
alzheimer phase 1 trial phase 3 phase 2 alzheimer’s alzheimer's
IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Published: 2021-05-14 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 8.0%
H: 3.7%
C: 1.48%
alzheimer phase 1 trial phase 3 phase 2 alzheimer’s alzheimer's
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021
Published: 2021-06-15 (Crawled : 13:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 1.86%
H: 1.22%
C: -3.66%
financial results results
IGC Form 10-K
Published: 2021-06-15 (Crawled : 13:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 1.86%
H: 1.22%
C: -3.66%
IGC Completes the Final Cohort of its Phase 1 Clinical Trial on Alzheimer’s Patients
Published: 2021-06-24 (Crawled : 01:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 17.57%
H: 9.2%
C: -5.17%
alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
Published: 2021-07-22 (Crawled : 16:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 165.54%
H: 18.32%
C: -28.75%
disease alzheimer treatment patent alzheimer’s alzheimer's disease alzheimer's
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
Published: 2021-12-02 (Crawled : 15:30) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 0.0%
H: 23.81%
C: -0.79%
new drug alzheimer dementia drug trial phase 1 phase 2 alzheimer’s alzheimer's
IGC FYE2022 Form 8-K Favorable Preliminary Clinical Trial Results
Published: 2021-12-02 (Crawled : 15:30) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 0.0%
H: 23.81%
C: -0.79%
trial trial results results
IGC FORM 10Q Quarter Ended September 30, 2022
Published: 2022-11-01 (Crawled : 23:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 4.33%
H: 0.0%
C: -10.4%
IGC Reports Financial Results for the Quarter Ended September 30, 2022
Published: 2022-11-01 (Crawled : 23:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 4.33%
H: 0.0%
C: -10.4%
financial
IGC Form 10-Q
Published: 2022-02-11 (Crawled : 19:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
| Email alert
Add to watchlist
IGC Reports Financial Results for the December 31, 2021 Quarter
Published: 2022-02-11 (Crawled : 19:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
| Email alert
Add to watchlist
financial results report results
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
Published: 2021-09-08 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: 6.92%
H: 1.76%
C: -7.06%
alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
IGC FYE2021 Proxy Card
Published: 2021-09-16 (Crawled : 02:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: -0.67%
H: 6.08%
C: 6.08%
IGC FYE2021 DEF 14A – Proxy Statement
Published: 2021-09-16 (Crawled : 02:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: -0.67%
H: 6.08%
C: 6.08%
IGC FYE2021 Form 8-K for ASM Results
Published: 2021-10-15 (Crawled : 22:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
| Email alert
Add to watchlist
results
IGC Announces Results of its 2021 Annual Stockholders Meeting
Published: 2021-10-15 (Crawled : 22:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
| Email alert
Add to watchlist
results
IGC FYE2022 Form 10-Q2
Published: 2021-10-30 (Crawled : 16:20) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
| Email alert
Add to watchlist
IGC Reports Financial Results for the September 30, 2021 Quarter
Published: 2021-10-30 (Crawled : 16:20) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
| Email alert
Add to watchlist
financial results results
IGC Form 8-K
Published: 2022-04-18 (Crawled : 22:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K
|
Health Technology
|
| O: -3.61%
H: 6.25%
C: 4.64%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.